Impact of Liver Metastases and Number of Metastatic Sites on Immune-Checkpoint Inhibitors Efficacy in Patients with Different Solid Tumors: A Retrospective Study.
Madeleine MaugeaisJulien PéronStéphane DalleAmélie BoespflugMichaël DuruissauxPauline CorbauxThibault ReverdyGulsum SahinAurélie RabierJonathan LopezNathalie FreymondDenis MailletPublished in: Biomedicines (2022)
The presence of LM or multiple MS were associated with poorer survival outcomes in patients treated with anti-PD(L)-1.